Permira Funds to acquire Corin, an orthopaedic company.

Global investment firm Permira acquired a majority stake in Corin, one of the fastest growing orthopaedic firms, from DeA Capital Alternative Funds, controlled by DeA Capital Group,, Hunt Capital, IP Investimenti e Partecipazioni and other investors, for an undisclosed sum. The investment provides substantial new funding to fuel the next stage of Corin’s development after 5 years of outstanding growth. Chief Executive Stefano Alfonsi and the management team will continue to lead Corin and will remain significant investors in the Company alongside the Permira Funds. Silvia Oteri, Partner in Permira’s Healthcare Team, added:“We are extremely excited to support Stefano Alfonsi and his outstanding management team in the next phase of Corin’s development. We have been following the orthopaedic industry for a long time and have been impressed by the rapid growth of challenger innovative companies like Corin. Since 2012, the Company has transformed from a basic orthopaedic manufacturer into a fast-growing international software-led orthopaedic-implant designer. We look forward to working with the team, and drawing on our significant healthcare and technology experience, to help the company capture further growth opportunities.”